Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Neomics has found a very promising target, AIMP2/AIMP2-DX2 for siRNA therapy application to tumoric lung cancer cells and we intend to focus the remaining resources on developing through clinical trials, the siRNA therapy as a first priority More
This technology overcomes the amount of time required to culture and identify pathogens, using standard collection methods, is able to identify over 98% of relevant pathogens, and is a fully automated process More
Direct gene amplification using AnyDirect solution gives reliable results from crude biospecimens without DNA isolation or any instrument. More
Disclosed herein are a pharmaceutical formulation with high stability and dissolution, and a method for preparing the pharmaceutical formulation, More
A DNA microarray that becomes a protein microarray on demand and provides an efficient systematic approach to the study of protein interactions and drug target identification and validation. More
A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
Dendritic cell (DC) generation and manipulation technology for the development of a cancer vaccine and rheumatoid arthritis (RA) therapeutics. Based on DC manipulating technology, Creagene is developing DC-based cancer vaccines against renal cell car More
Therapeutic method to treat prostate carcinomas by administration of cellular PAcP protein. More
A rapid and automated method for discovering potential drugs for the treatment of sickle cell anemia, using a combination of laser photolysis and statistical processing of digital images. More
Related Reports
Market Research Reports provided by reports.innovaro.com
Dec 2008 - 35 pages - $200
Dec 2010 - 15 pages - $500
Dec 2010 - 16 pages - $500
May 2011 - 15 pages - $250
Dec 2010 - 25 pages - $500
Dec 2007 - 65 pages - $3,395
Apr 2008 - 39 pages - $495
Sep 2011 - 30 pages - $250
Sep 2011 - 37 pages - $250
Mar 2011 - 26 pages - $500
Your selection
- Industry sector
- Biotechnology del
Browse By
- Industry sector
- Assay systems
- Diagnostic test systems
- Gene therapy
- Human diagnostics
- Human therapeutics
- Nanotechnology
- Other
- Research supplies
- Stem cells
- Therapeutic target
- Accident and Trauma
- Allergy
- Blood and forming organs
- Cardiovascular
- Central Nervous System
- Dermatological
- Endocrinology
- Gastrointestinal
- Genetic disorders
- Genito-urinary
- Hospital and Surgery
- Immune related disorders
- Infectious diseases
- Metabolism
- Musculoskeletal
- Oncology
- Oral Health
- Other therapeutic
- Respiratory
- Sensory organ
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us